1,355,811 Shares in Globe Life Inc. $GL Acquired by Pzena Investment Management LLC

Pzena Investment Management LLC purchased a new stake in shares of Globe Life Inc. (NYSE:GL) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 1,355,811 shares of the company’s stock, valued at approximately $242,256,000. Pzena Investment Management LLC owned approximately 1.75% of Globe Life at the end of the most recent reporting period.

Several other institutional investors have also recently bought and sold shares of GL. Vanguard Group Inc. boosted its stake in Globe Life by 0.9% in the fourth quarter. Vanguard Group Inc. now owns 10,090,885 shares of the company’s stock worth $1,411,311,000 after purchasing an additional 86,349 shares in the last quarter. BlackRock Inc. acquired a new stake in shares of Globe Life in the second quarter valued at $987,901,000. Invesco Ltd. increased its stake in shares of Globe Life by 2.7% in the fourth quarter. Invesco Ltd. now owns 3,948,676 shares of the company’s stock valued at $552,262,000 after buying an additional 102,445 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in shares of Globe Life by 10.2% in the first quarter. Dimensional Fund Advisors LP now owns 2,353,192 shares of the company’s stock valued at $327,479,000 after buying an additional 217,331 shares in the last quarter. Finally, Morgan Stanley raised its holdings in shares of Globe Life by 7.2% in the fourth quarter. Morgan Stanley now owns 1,860,257 shares of the company’s stock valued at $260,176,000 after buying an additional 125,567 shares during the last quarter. Institutional investors own 81.61% of the company’s stock.

Insider Buying and Selling at Globe Life

In related news, CFO Thomas Peter Kalmbach sold 21,000 shares of the stock in a transaction that occurred on Thursday, July 30th. The shares were sold at an average price of $180.06, for a total value of $3,781,260.00. Following the transaction, the chief financial officer directly owned 50,568 shares in the company, valued at $9,105,274.08. This represents a 29.34% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Cheryl Alston sold 8,258 shares of the firm’s stock in a transaction that occurred on Thursday, June 25th. The shares were sold at an average price of $179.24, for a total transaction of $1,480,163.92. Following the completion of the transaction, the director directly owned 16,621 shares in the company, valued at approximately $2,979,148.04. The trade was a 33.19% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 179,844 shares of company stock valued at $31,616,279 over the last 90 days. Company insiders own 2.11% of the company’s stock.

Globe Life Price Performance

Shares of GL stock opened at $180.00 on Tuesday. The firm has a market cap of $13.83 billion, a price-to-earnings ratio of 11.95 and a beta of 0.48. Globe Life Inc. has a 12 month low of $127.85 and a 12 month high of $191.55. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.43. The stock has a 50-day moving average price of $177.61 and a 200 day moving average price of $157.71.

Globe Life (NYSE:GL) last released its earnings results on Wednesday, July 22nd. The company reported $3.61 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.67 by ($0.06). Globe Life had a net margin of 19.58% and a return on equity of 20.52%. The business had revenue of $1.60 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same quarter in the previous year, the company posted $3.05 earnings per share. The business’s revenue for the quarter was up 8.0% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. Research analysts expect that Globe Life Inc. will post 15.71 EPS for the current year.

Globe Life declared that its board has initiated a stock buyback program on Monday, August 10th that authorizes the company to repurchase $2.50 billion in outstanding shares. This repurchase authorization authorizes the company to repurchase up to 17.7% of its stock through open market purchases. Stock repurchase programs are generally a sign that the company’s leadership believes its shares are undervalued.

Globe Life Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Monday, October 5th will be paid a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Monday, October 5th. Globe Life’s payout ratio is 8.76%.

Wall Street Analysts Forecast Growth

GL has been the topic of several research reports. JPMorgan Chase & Co. upped their price target on shares of Globe Life from $181.00 to $201.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 21st. TD Cowen raised their price objective on shares of Globe Life from $215.00 to $225.00 and gave the company a “buy” rating in a research report on Wednesday, July 22nd. Keefe, Bruyette & Woods dropped their target price on shares of Globe Life from $192.00 to $190.00 and set an “outperform” rating for the company in a research note on Friday, July 24th. Morgan Stanley boosted their target price on shares of Globe Life from $181.00 to $208.00 and gave the stock an “overweight” rating in a research note on Monday, July 6th. Finally, Jefferies Financial Group upped their target price on shares of Globe Life from $147.00 to $166.00 and gave the stock a “hold” rating in a research report on Friday, July 10th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $191.67.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.